Join the Oncology Voice Network. Join for Free
Why Medical Affairs Needs More Leadership
Medical Affairs Leadership Leadership Development Patient-Centric Leadership Oncology Field Medical Leadership Training

Why Medical Affairs Needs More Leadership


Share This Article


Summary

In this episode, Scott Conry joins Tom Caravela to delve into the nuances of leadership within medical affairs. Scott shares his extensive experiences and challenges faced in leadership roles, offering insights into the development of essential leadership skills and building trust. The discussion covers tips for emerging leaders, the differences between in-house and outsourced leadership training, and fostering a leadership culture. Scott reflects on his journey, lessons learned from mistakes, and evolving trends in the field, emphasizing patient-centric leadership. The episode wraps up with closing thoughts and a preview of the next episode.

Today’s guest is Scott Conry, Vice President, Head Oncology Field Medical at GSK discusses why Medical Affairs needs more leadership.

Scott shares….

👉 What it takes to be a great leader
👉 Why there is a need for companies to develop people
👉 What people need to do to stand out and position themselves for growth 
👉 How GOOD leaders unlock the potential of their team
👉 Thoughts on outsourcing leadership development
👉 What medical affairs needs to do to evolve

Click for Source
Medical Affairs Leadership, Leadership Development, Patient-Centric Leadership, Oncology Field Medical, Leadership Training

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Medical affairs: The power behind redefining commercialization
Partner Avatar Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Podcast
Soft Skills & Leadership Advice for Introverts: In an Extrovert World
Partner Avatar MSL Talk: Tom Caravela, Josh Kosnick

Soft Skills & Leadership Advice for Introverts: In an Extrovert World

Podcast
Emotional Intelligence and the MSL: More Important than EVER
Partner Avatar MSL Talk: Tom Caravela, Doug Yau

Emotional Intelligence and the MSL: More Important than EVER

Article
Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology
OVN Avatar Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri

Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Explore OVN